Literature DB >> 28199911

The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia.

Qiongzhen Li1, Xiangdong Du2, Yingyang Zhang2, Guangzhong Yin2, Guangya Zhang2, Consuelo Walss-Bass3, João Quevedo3, Jair C Soares3, Haishen Xia4, Xiaosi Li4, Yingjun Zheng5, Yuping Ning5, Xiang Yang Zhang6.   

Abstract

Obesity is a common comorbidity in schizophrenia. Few studies have addressed obesity in Chinese schizophrenia patients. The aims of this current study were to evaluate the prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia. A total of 206 patients were recruited from a hospital in Beijing. Their clinical and anthropometric data together with plasma glucose and lipid parameters were collected. Positive and Negative Syndrome Scale (PANSS) was rated for all patients. Overall, 43 (20.9%) patients were obese and 67 (32.5%) were overweight. The obese patients had significantly higher glucose levels, triglyceride levels than non-obese patients. Females and patients with type 2 diabetes mellitus had increased risk for obesity. Correlation analysis showed that BMI was associated with sex, education levels, negative symptoms, total PANSS score, triglyceride levels and type 2 diabetes mellitus. Further stepwise regression analysis showed that sex, type 2 diabetes, education level, triglyceride and amount of smoking/day were significant predictors for obesity. Our study showed that the prevalence of obesity in Chinese patients with schizophrenia is higher than that in the general population. Some demographic and clinical variables are risk factors for obesity in schizophrenia.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  BMI; Chinese; Obesity; PANSS; Schizophrenia

Mesh:

Substances:

Year:  2016        PMID: 28199911     DOI: 10.1016/j.psychres.2016.12.041

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

1.  The prevalence and independent influencing factors of obesity and underweight in patients with schizophrenia: a multicentre cross-sectional study.

Authors:  Juan Wang; Yulong Zhang; Yating Yang; Zhiwei Liu; Lei Xia; Wenzheng Li; Zhongxiang Li; Xinhui Xie; Wenfeng Deng; Kai Zhang; Huanzhong Liu
Journal:  Eat Weight Disord       Date:  2020-06-17       Impact factor: 4.652

Review 2.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

3.  Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysis.

Authors:  Chuanjun Zhuo; Patrick Todd Triplett
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

4.  Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls.

Authors:  Yang Tian; Dongmei Wang; Gaoxia Wei; Jiesi Wang; Huixia Zhou; Hang Xu; Qilong Dai; Meihong Xiu; Dachun Chen; Li Wang; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2020-11-25       Impact factor: 4.530

5.  Lower risk of liver cancer in patients with schizophrenia: a systematic review and meta-analysis of cohort studies.

Authors:  Dali Xu; Guangdong Chen; Lingguang Kong; Wei Zhang; Lirong Hu; Ce Chen; Jie Li; Chuanjun Zhuo
Journal:  Oncotarget       Date:  2017-10-09

6.  Organization of future training in bariatric gastroenterology.

Authors:  Timothy R Koch; Timothy R Shope; Christopher J Gostout
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

7.  Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients.

Authors:  Huimei An; Xiangdong Du; Xingbing Huang; Lingyan Qi; Qiufang Jia; Guangzhong Yin; Chunling Xiao; Xu-Feng Huang; Yuping Ning; Ryan M Cassidy; Li Wang; Jair C Soares; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2018-11-29       Impact factor: 6.222

8.  Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia.

Authors:  Chang Wei Wei; Ying Qi Chen; Mi Ma; Mei Hong Xiu; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2020-01-21       Impact factor: 6.222

Review 9.  The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications.

Authors:  Tomasz Szeligowski; Alexandra Lim Yun; Belinda R Lennox; Philip W J Burnet
Journal:  Front Psychiatry       Date:  2020-03-12       Impact factor: 4.157

10.  Neuregulin 3 rs10748842 polymorphism contributes to the effect of body mass index on cognitive impairment in patients with schizophrenia.

Authors:  Yongjie Zhou; Yuhuan Li; Yujie Meng; Jiesi Wang; Fengchun Wu; Yuping Ning; Yi Li; Ryan M Cassidy; Zezhi Li; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2020-02-11       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.